Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Enteric Dysfunctions in Experimental Parkinson’s Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats
Matteo Fornai, Carolina Pellegrini, Luca Antonioli, Cristina Segnani, Chiara Ippolito, Elisabetta Barocelli, Vigilio Ballabeni, Gaia Vegezzi, Zainab Al Harraq, Fabio Blandini, Giovanna Levandis, Silvia Cerri, Corrado Blandizzi, Nunzia Bernardini and Rocchina Colucci
Journal of Pharmacology and Experimental Therapeutics February 2016, 356 (2) 434-444; DOI: https://doi.org/10.1124/jpet.115.228510
Matteo Fornai
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Carolina Pellegrini
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Luca Antonioli
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Cristina Segnani
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Chiara Ippolito
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Elisabetta Barocelli
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Vigilio Ballabeni
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Gaia Vegezzi
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Zainab Al Harraq
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Fabio Blandini
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Giovanna Levandis
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Silvia Cerri
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Corrado Blandizzi
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Nunzia Bernardini
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Rocchina Colucci
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy (M.F., C.P., L.A., C.S., C.I., C.B., N.B.); Department of Pharmacy, University of Parma, Parma, Italy (E.B., V.B., G.V., Z.A.H.); Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, “C. Mondino” National Neurologic Institute, Pavia, Italy (F.B., G.L., S.C.); and Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy (R.C.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Parkinson’s Disease and Colonic Motility
Matteo Fornai, Carolina Pellegrini, Luca Antonioli, Cristina Segnani, Chiara Ippolito, Elisabetta Barocelli, Vigilio Ballabeni, Gaia Vegezzi, Zainab Al Harraq, Fabio Blandini, Giovanna Levandis, Silvia Cerri, Corrado Blandizzi, Nunzia Bernardini and Rocchina Colucci
Journal of Pharmacology and Experimental Therapeutics February 1, 2016, 356 (2) 434-444; DOI: https://doi.org/10.1124/jpet.115.228510
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Parkinson’s Disease and Colonic Motility
Matteo Fornai, Carolina Pellegrini, Luca Antonioli, Cristina Segnani, Chiara Ippolito, Elisabetta Barocelli, Vigilio Ballabeni, Gaia Vegezzi, Zainab Al Harraq, Fabio Blandini, Giovanna Levandis, Silvia Cerri, Corrado Blandizzi, Nunzia Bernardini and Rocchina Colucci
Journal of Pharmacology and Experimental Therapeutics February 1, 2016, 356 (2) 434-444; DOI: https://doi.org/10.1124/jpet.115.228510
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement